CAR-T Cell Therapy Market By Type of Targeted Antigens (CD19, CD20, CD22, CD30, CD33, BCMA, MSLN), By Type of Approach (Autologous and Allogeneic), By Therapeutic Areas (Acute lymphoblastic leukemia (ALL), Diffuse large B-Cell lymphoma (DLBCL), Multiple Myeloma (MM), Acute Myeloid Leukemia (AML) and Others), By Product (Axicabtagene Ciloleucel, Tisagenlecleucel, Lisocabtagene Maraleucel, Bb2121), By End Users (Hospitals, Cancer Treatment Centers) – Growth, Future prospects & Analysis 2024-2032